DECN
DECISION DIAGNOSTICS CORP
stockOTC

decision diagnostics corp. develops smart phone based electronic medical record (emr) technologies. the company offers prescription and non-prescription diagnostics; home testing products for the chronically ill; fulfillment services to direct to patient diabetes programs; and cell phone centric e-health products and technologies development services. it manufactures and distributes genultimate! glucose test strips, a class ii medical device for at-home use for the measurement of glucose; petsure! glucose test strip for the glucose testing of dogs and cats designed to work with the zoetis alphatrak and alphatrak ii glucometers, a legacy meter; genultimate! 4pets glucose system, a proprietary glucose measuring system, including genultimate! 4pets test strip and avantage meter, for the testing of dogs, cats, and horses; and genultimate! sure and genultimate! precis test strips. in addition, it engages in the acquisition and holding of intellectual property including patents and trademark

DECISION DIAGNOSTICS CORP (OTC:DECN) stock price today is $0.00, and today's volume is 8,000. DECN is up 0.000% today. The 30 day average volume is 31,382. DECN market cap is $380 with 380.49M shares outstanding.